ES541450A0 - Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas. - Google Patents
Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.Info
- Publication number
- ES541450A0 ES541450A0 ES541450A ES541450A ES541450A0 ES 541450 A0 ES541450 A0 ES 541450A0 ES 541450 A ES541450 A ES 541450A ES 541450 A ES541450 A ES 541450A ES 541450 A0 ES541450 A0 ES 541450A0
- Authority
- ES
- Spain
- Prior art keywords
- heteroazolidindionas
- spire
- procedure
- preparation
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59301284A | 1984-03-23 | 1984-03-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES541450A0 true ES541450A0 (es) | 1986-04-16 |
| ES8606295A1 ES8606295A1 (es) | 1986-04-16 |
Family
ID=24372993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES541450A Expired ES8606295A1 (es) | 1984-03-23 | 1985-03-21 | Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0159143B1 (es) |
| JP (1) | JPS60209572A (es) |
| KR (1) | KR850006188A (es) |
| AU (1) | AU563668B2 (es) |
| CA (1) | CA1244443A (es) |
| DE (1) | DE3561198D1 (es) |
| DK (1) | DK131885A (es) |
| ES (1) | ES8606295A1 (es) |
| FI (1) | FI851170A7 (es) |
| GR (1) | GR850704B (es) |
| HU (1) | HU195783B (es) |
| IL (1) | IL74667A (es) |
| PH (1) | PH23921A (es) |
| PL (1) | PL145198B1 (es) |
| PT (1) | PT80145B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| ATE516803T1 (de) | 2003-03-14 | 2011-08-15 | Merck Sharp & Dohme | Aryl-spirohydantoin-cgrp-rezeptor-antagonisten |
| ATE518852T1 (de) * | 2004-09-13 | 2011-08-15 | Merck Sharp & Dohme | Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten |
| US8071770B2 (en) | 2005-11-18 | 2011-12-06 | Merck Sharp & Dohme Corp. | Spirohydantoin aryl CGRP receptor antagonists |
| CN111732545B (zh) * | 2020-06-08 | 2023-03-10 | 华侨大学 | 一种2,3-二氢螺[咪唑-4,1′-茚]类化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| ES8400116A1 (es) * | 1981-10-13 | 1983-10-16 | Pfizer | "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona". |
| ZA832679B (en) * | 1982-05-07 | 1983-12-28 | Ici Plc | Indoline derivatives |
| US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
-
1985
- 1985-03-15 DE DE8585301809T patent/DE3561198D1/de not_active Expired
- 1985-03-15 EP EP85301809A patent/EP0159143B1/en not_active Expired
- 1985-03-19 PH PH32003A patent/PH23921A/en unknown
- 1985-03-20 IL IL74667A patent/IL74667A/xx unknown
- 1985-03-20 GR GR850704A patent/GR850704B/el unknown
- 1985-03-21 KR KR1019850001848A patent/KR850006188A/ko not_active Ceased
- 1985-03-21 ES ES541450A patent/ES8606295A1/es not_active Expired
- 1985-03-21 CA CA000477079A patent/CA1244443A/en not_active Expired
- 1985-03-21 PT PT80145A patent/PT80145B/pt unknown
- 1985-03-21 PL PL1985252487A patent/PL145198B1/pl unknown
- 1985-03-22 FI FI851170A patent/FI851170A7/fi not_active Application Discontinuation
- 1985-03-22 JP JP60057640A patent/JPS60209572A/ja active Pending
- 1985-03-22 AU AU40251/85A patent/AU563668B2/en not_active Ceased
- 1985-03-22 HU HU851108A patent/HU195783B/hu not_active IP Right Cessation
- 1985-03-22 DK DK131885A patent/DK131885A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU563668B2 (en) | 1987-07-16 |
| JPS60209572A (ja) | 1985-10-22 |
| PT80145A (en) | 1985-04-01 |
| DK131885D0 (da) | 1985-03-22 |
| FI851170L (fi) | 1985-09-24 |
| DE3561198D1 (en) | 1988-01-28 |
| IL74667A0 (en) | 1985-06-30 |
| PL145198B1 (en) | 1988-08-31 |
| CA1244443A (en) | 1988-11-08 |
| EP0159143B1 (en) | 1987-12-16 |
| KR850006188A (ko) | 1985-10-02 |
| HU195783B (en) | 1988-07-28 |
| PL252487A1 (en) | 1985-10-08 |
| FI851170A0 (fi) | 1985-03-22 |
| GR850704B (es) | 1985-07-19 |
| PT80145B (en) | 1987-03-23 |
| EP0159143A1 (en) | 1985-10-23 |
| DK131885A (da) | 1985-09-24 |
| FI851170A7 (fi) | 1985-09-24 |
| HUT37603A (en) | 1986-01-23 |
| PH23921A (en) | 1990-01-23 |
| ES8606295A1 (es) | 1986-04-16 |
| IL74667A (en) | 1988-12-30 |
| AU4025185A (en) | 1985-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES545464A0 (es) | Un procedimiento para la preparacion de tetrahidroftalimidas. | |
| ES540705A0 (es) | Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas. | |
| ES544644A0 (es) | Un procedimiento para la preparacion de derivados de carboxamidoadenosina. | |
| ES555834A0 (es) | Un procedimiento para la preparacion de nuevas piranopiridinas. | |
| ES551249A0 (es) | Un procedimiento para la preparacion de peptidilaminodioles. | |
| ES556738A0 (es) | Un procedimiento para la preparacion de nuevos piridazinaminas. | |
| ES541200A0 (es) | Un procedimiento para la preparacion de un derivado de dibenzoilmetano. | |
| ES533753A0 (es) | Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas. | |
| ES546236A0 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
| ES540609A0 (es) | Un procedimiento para la preparacion de pirazolo piridinas. | |
| ES554983A0 (es) | Un procedimiento para la preparacion de silileteres. | |
| ES540610A0 (es) | Un procedimiento para la preparacion de pirazolopiridinas. | |
| ES546872A0 (es) | Un procedimiento para la preparacion de aminoalcoxibenzopiranonas. | |
| ES544521A0 (es) | Un procedimiento para la preparacion de triazolobenzodiazefinas. | |
| ES557076A0 (es) | Un procedimiento para la preparacion de nuevas benzamidas sustituidas. | |
| ES541781A0 (es) | Un procedimiento para la preparacion de nuevos benzotiopenos. | |
| ES550504A0 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
| ES547805A0 (es) | Un procedimiento para la preparacion de nuevos derivados de guanina. | |
| ES555369A0 (es) | Un procedimiento para la preparacion de un polialquenoilisocianato. | |
| ES540200A0 (es) | Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos | |
| ES539543A0 (es) | Un procedimiento para la preparacion de nuevos compuestos de oxadiazinona. | |
| ES547205A0 (es) | Un procedimiento para la preparacion de nuevas quinazolindionas. | |
| ES555723A0 (es) | Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas. | |
| ES516184A0 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
| ES542882A0 (es) | Un procedimiento para la preparacion de nuevas sulfonilureas. |